Accessing targeted nanoparticles to the brain: the vascular route

Area of Science:

• Neuroscience
• Biotechnology
• Pharmacology

Background:

• The blood-brain barrier (BBB) restricts the passage of many drugs, particularly hydrophilic molecules, into the central nervous system (CNS).
• Nanoparticle drug carriers offer a promising strategy to overcome BBB limitations for delivering therapeutics like proteins and genetic material.
• Targeting specific receptors on brain capillary endothelial cells is key for enabling nanoparticle transport across the BBB.

Purpose of the Study:

• To review the potential of nanoparticles for targeting the BBB.
• To examine mechanisms of nanocarrier entry and transport through brain endothelium.
• To discuss challenges posed by the brain capillary basement membrane to nanoparticle-mediated drug delivery.

Main Methods:

• Review of current literature on nanoparticle targeting strategies for the BBB.
• Analysis of receptor-mediated transcytosis mechanisms for nanocarriers.
• Evaluation of physical barriers at the BBB, including the extracellular matrix.

Main Results:

• Transferrin and anti-transferrin receptor antibodies are leading ligands for BBB targeting.
• Nanoparticles can be engineered to interact with and potentially cross brain capillary endothelial cells.
• The extracellular matrix of the basement membrane presents a significant physical obstacle for nanoparticle transport.

Conclusions:

• Targeted nanoparticles show potential for CNS drug delivery by overcoming the BBB.
• Understanding BBB transport mechanisms and physical barriers is crucial for effective nanocarrier design.
• Further research is needed to optimize nanoparticle strategies for efficient brain drug delivery.